CONFORMATIONAL-ANALYSIS OF CCK-B AGONISTS USING H-1-NMR AND RESTRAINED MOLECULAR-DYNAMICS - COMPARISON OF BIOLOGICALLY-ACTIVE BOC-TRP-(N-ME)NLE-ASP-PHE-NH2 AND INACTIVE BOC-TRP-(N-ME)PHE-ASP-PHE-NH2

被引:27
作者
GOUDREAU, N
WENG, JH
ROQUES, BP
机构
[1] Laboratoire de Pharmacochimie Moléculaire Et Structurale, U 266 Inserm, Ura D1500 Cnrs, Faculté de Pharmacie, Paris, 75006
关键词
D O I
10.1002/bip.360340202
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tetrapeptide Boc-Trp-(N-Me) Nle-Asp-Phe-NH2 is a potent CCK-B agonist. Replacement in this analogue of the norleucine residue by a phenylalanine, to yield Boc-Trp-(N-Me)Phe-Asp-Phe-NH2, led to a 740-fold decrease in affinity whereas the same decrease in affinity was not observed in their nonmethylated counterparts. In order to ascertain the conformational preferences of these two N-methylated tetrapeptides, a study by two-dimensional (2D) nmr spectroscopy and molecular modeling was undertaken. The solution conformation of the two peptides was examined by H-1-nmr in a d(6)-DMSO/H2O (80 : 20) mixture. A cis-trans equilibrium, induced by N-methylation, was observed for both analogues, and the proton spectra of the two rotamers were fully characterized in each case. H-1-H-1 distance constraints, derived from 2D nuclear Overhauser effect spectroscopy and rotating frame nuclear Overhauser effect spectroscopy experiments, were used as inputs for subsequent restrained molecular dynamics simulations. Comparisons of the nmr and molecular modeling data point toward distinct conformational preferences for these two peptides with an opposite spatial orientation of the Trp residue, and could explain the large difference in their biological activities. Furthermore, the tridimensional structure of Boc-Trp-(N-Me) Nle-Asp-Phe-NH2 could serve as a model for the design of nonpeptide CCK-B agonists. (C) 1994 John Wiley and Sons, Inc.
引用
收藏
页码:155 / 169
页数:15
相关论文
共 56 条
[1]  
ABILLON E, 1981, INT J PEPT PROT RES, V17, P480
[2]   THE ROLE OF CCK, CERULEIN, AND CCK ANTAGONISTS IN NOCICEPTION [J].
BABER, NS ;
DOURISH, CT ;
HILL, DR .
PAIN, 1989, 39 (03) :307-328
[3]  
BASUS VJ, 1989, METHOD ENZYMOL, V177, P132
[4]   PRACTICAL ASPECTS OF TWO-DIMENSIONAL TRANSVERSE NOE SPECTROSCOPY [J].
BAX, A ;
DAVIS, DG .
JOURNAL OF MAGNETIC RESONANCE, 1985, 63 (01) :207-213
[5]  
BRADWEJN J, 1991, ARCH GEN PSYCHIAT, V48, P603
[6]  
BRADWEJN J, 1992, CLIN NEUROPHARM S1, V15, P9
[7]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[8]  
BYSTROV VF, 1976, PROGR NMR SPECTROSCO, V10, P41
[9]   ENZYME-RESISTANT CCK ANALOGS WITH HIGH AFFINITIES FOR CENTRAL RECEPTORS [J].
CHARPENTIER, B ;
DURIEUX, C ;
PELAPRAT, D ;
DOR, A ;
REIBAUD, M ;
BLANCHARD, JC ;
ROQUES, BP .
PEPTIDES, 1988, 9 (04) :835-841
[10]   CCK-B AGONIST OR ANTAGONIST ACTIVITIES OF STRUCTURALLY HINDERED AND PEPTIDASE-RESISTANT BOC-CCK4 DERIVATIVES [J].
CORRINGER, PJ ;
WENG, JH ;
DUCOS, B ;
DURIEUX, C ;
BOUDEAU, P ;
BOHME, A ;
ROQUES, BP .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (01) :166-172